Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.15 +0.11 (+2.72%)
At close: Sep 29, 2026 · 4:00 PM EDT

Adial Pharmaceuticals (ADIL) Non-Current Assets (2017 - 2026)

Updated

Adial Pharmaceuticals (ADIL) recorded Non-Current Assets of $244,000 in Q2 2026, down 92.9% from $3.45 million a year earlier and down 42.5% from the prior quarter.

Analysis

Adial Pharmaceuticals (ADIL) Non-Current Assets (2017 - 2026) Analysis & Trends

At the end of FY2025, Adial Pharmaceuticals reported Non-Current Assets of $3.44 million, down 2.0% from FY2024.

  • Annual Non-Current Assets has a five-year compound annual growth rate of 57.4% (FY2020 to FY2025).
  • Across earlier years, Non-Current Assets came in at $3.51 million in FY2024 (+4.7%), $3.35 million in FY2023 (+253.0%), $948,392 in FY2022 (-6.4%) and $1.01 million in FY2021 (+185.0%).
  • The Q2 2026 figure is the lowest quarterly Non-Current Assets since Q3 2020.
  • On a year-over-year basis, Non-Current Assets has declined for six consecutive quarters, with an average decline of 34.3% over the last eight quarters.
  • Peak year-over-year performance for Non-Current Assets in the last five years was growth of 308.7% in Q1 2024, against a decline of 92.9% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $424,373 (Q1 2026), $3.44 million (Q4 2025) and $646,015 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Adial Pharmaceuticals 18.67 Mn 18.67 Mn - 244,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 244,000.00
Mar 31, 2026 424,373.00
Dec 31, 2025 3.44 Mn
Sep 30, 2025 646,015.00
Jun 30, 2025 3.45 Mn
Mar 31, 2025 3.47 Mn
Dec 31, 2024 3.51 Mn
Sep 30, 2024 3.51 Mn
Jun 30, 2024 3.81 Mn
Mar 31, 2024 3.83 Mn
Dec 31, 2023 3.35 Mn
Sep 30, 2023 3.37 Mn
Jun 30, 2023 1.73 Mn
Mar 31, 2023 937,028.00
Dec 31, 2022 948,392.00
Sep 30, 2022 968,415.00
Jun 30, 2022 983,677.00
Mar 31, 2022 998,659.00
Dec 31, 2021 1.01 Mn
Sep 30, 2021 2.46 Mn
API Access

Adial Pharmaceuticals Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=ADIL&period=max&api_key=YOUR_API_KEY